overall survival

Brufsky AM, Finn RS, Metzger O, Goncalves R, Huang-Bartlett C, Sreenivasan S, Nur U, Davies J, Grigorenko A, Long GH. Comparative effectiveness of CDK4/6 inhibitors[...]

By afschroeder • March 8, 2026

Pistilli B, Jhaveri K, Im SA, Pernas S, De Laurentiis M, Wang S, Jañez NM, Borges G, Cescon DW, Hattori M, Lu YS, Hamilton E,[...]

By sjmartinez • December 26, 2025

Nishio M, Seto T, Reck M, Garon EB, Nishio K, Kasahara K, Nishino K, Satouchi M, Yoh K, Hayashi H, Sakai K, Enatsu S, Matsui[...]

By afschroeder • November 25, 2025

Zheng Y, Zhang D, Sun Q, Lu J. Refining Prognostic Predictions and Risk Assessment in Head and Neck Rhabdomyosarcoma. Laryngoscope. 2025 Oct 23. doi: 10.1002/lary.70200. Epub[...]

By afschroeder • October 23, 2025

Newman-Hung NJ, Khabaz K, Ding R, Pham D, Jackson NJ, Hsu W, Bernthal NM, Wessel LE. Limitations of Currently Available Sarcoma Prediction Tools in a[...]

By afschroeder • August 24, 2025

Chan AA, Noguti J, Ramirez NM, Navarrete M, Lee DJ. Primary Cutaneous Melanoma Microbiome is Associated with Overall Survival and Recurrence. J Invest Dermatol. 2025[...]

By afschroeder • August 21, 2025

Ledermann JA, Oza AM, Lorusso D, Aghajanian C, Oaknin A, Dean A, Colombo N, Weberpals JI, Clamp AR, Scambia G, Leary A, Holloway RW, Gancedo[...]

By sjmartinez • July 1, 2025

Powles TB, Van der Heijden MS, Loriot Y, Bedke J, Valderrama BP, Iyer G, Kikuchi E, Hoffman-Censits J, Vulsteke C, Drakaki A, Rausch S, Arafat[...]

By sjmartinez • June 4, 2025

Nishio M, Seto T, Reck M, Garon EB, Nishio K, Kasahara K, Nishino K, Satouchi M, Yoh K, Hayashi H, Sakai K, Enatsu S, Frimodt-Møller[...]

By sjmartinez • June 3, 2025

Kudo M, Yamashita T, Finn RS, Galle PR, Ducreux M, Cheng AL, Tsuchiya K, Sakamoto N, Hige S, Take R, Yamada K, Nakagawa Y, Takahashi[...]

By sjmartinez • May 7, 2025